Geron Corporation (NASDAQ: GERN) today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE